Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | H3N |
| Molecular Weight | 17.0305 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
N
InChI
InChIKey=QGZKDVFQNNGYKY-UHFFFAOYSA-N
InChI=1S/H3N/h1H3
| Molecular Formula | H3N |
| Molecular Weight | 17.0305 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
The ammonium cation is a positively charged polyatomic ion with the chemical formula NH4+. Ammonium ions are a waste product of the metabolism of animals. In fish and aquatic invertebrates, it is excreted directly into the water. In mammals, sharks, and amphibians, it is converted in the urea cycle to urea, because urea is less toxic and can be stored more efficiently. In birds, reptiles, and terrestrial snails, metabolic ammonium is converted into uric acid, which is solid and can therefore be excreted with minimal water loss. Ammonium is an important source of nitrogen for many plant species, especially those growing on hypoxic soils. However, it is also toxic to most crop species and is rarely applied as a sole nitrogen source. The ammonium ion (NH4+) in the body plays an important role in the maintenance of acid-base balance. The kidney uses ammonium (NH4+) in place of sodium (Na+) to combine with fixed anions in maintaining acid-base balance, especially as a homeostatic compensatory mechanism in metabolic acidosis. When a loss of hydrogen ions (H+) occurs and serum chloride (Cl–) decreases, sodium is made available for combination with bicarbonate (HCO3–). This creates an excess of sodium bicarbonate (NaHCO3) which leads to a rise in blood pH and a state of metabolic alkalosis. The therapeutic effects of Ammonium (as Ammonium Chloride) depend upon the ability of the kidney to utilize ammonia in the excretion of an excess of fixed anions and the conversion of ammonia to urea by the liver, thereby liberating hydrogen (H+) and chloride (Cl–) ions into the extracellular fluid.
CNS Activity
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL217 Sources: https://www.ncbi.nlm.nih.gov/pubmed/3743637 |
2.2 nM [IC50] | ||
Target ID: CHEMBL1947 Sources: www.ncbi.nlm.nih.gov/pubmed/22324546 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | AMMONIUM CHLORIDE Approved UseUnknown Launch Date1984 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Ammonia impairs glutamatergic communication in astroglial cells: protective role of resveratrol. | 2015-12 |
|
| Lipoic acid protects C6 cells against ammonia exposure through Na⁺-K⁺-Cl⁻ co-transporter and PKC pathway. | 2013-10 |
|
| High brain ammonia tolerance and down-regulation of Na+:K+:2Cl(-) Cotransporter 1b mRNA and protein expression in the brain of the Swamp Eel, Monopterus albus, exposed to environmental ammonia or terrestrial conditions. | 2013 |
|
| Molecular characterization of branchial aquaporin 1aa and effects of seawater acclimation, emersion or ammonia exposure on its mRNA expression in the gills, gut, kidney and skin of the freshwater climbing perch, Anabas testudineus. | 2013 |
|
| Combined effects of high environmental ammonia, starvation and exercise on hormonal and ion-regulatory response in goldfish (Carassius auratus L.). | 2012-06-15 |
|
| Resveratrol prevents ammonia toxicity in astroglial cells. | 2012 |
|
| [Effect of jianpi yiqi qingyou decoction on lymphocyte subsets and IL-2 mRNA in gastric tissue in rats with chronic superficial gastritis]. | 2011-04 |
|
| Role of the Rhesus glycoprotein, Rh B glycoprotein, in renal ammonia excretion. | 2010-11 |
|
| Increased Na, K-ATPase alpha2 isoform gene expression by ammonia in astrocytes and in brain in vivo. | 2010-11 |
|
| Molecular basis of inhibition of substrate hydrolysis by a ligand bound to the peripheral site of acetylcholinesterase. | 2010-09-06 |
|
| Effect of intercalated cell-specific Rh C glycoprotein deletion on basal and metabolic acidosis-stimulated renal ammonia excretion. | 2010-08 |
|
| NHE4 is critical for the renal handling of ammonia in rodents. | 2010-06 |
|
| Glutamine synthetase in muscle is required for glutamine production during fasting and extrahepatic ammonia detoxification. | 2010-03-26 |
|
| Ammonia and proinflammatory cytokines modify expression of genes coding for astrocytic proteins implicated in brain edema in acute liver failure. | 2010-03 |
|
| [Ammonia as a cause for hepatic encephalopathy]. | 2010-02 |
|
| Ammonia toxicity to the brain: effects on creatine metabolism and transport and protective roles of creatine. | 2010 |
|
| In vivo monitoring of extracellular 13N-glutamine derived from blood-borne 13N-ammonia in rat striatum using microdialysis with radio-LC method. | 2009-10-30 |
|
| Collecting duct-specific Rh C glycoprotein deletion alters basal and acidosis-stimulated renal ammonia excretion. | 2009-06 |
|
| Protein kinase G is involved in ammonia-induced swelling of astrocytes. | 2009-05 |
|
| Ammonia transport in cultured gill epithelium of freshwater rainbow trout: the importance of Rhesus glycoproteins and the presence of an apical Na+/NH4+ exchange complex. | 2009-03 |
|
| Encapsulation of glutamine synthetase in mouse erythrocytes: a new procedure for ammonia detoxification. | 2008-12 |
|
| Ammonia metabolism capacity of HepG2 cells with high expression of human glutamine synthetase. | 2008-12 |
|
| The effects of CO2 and external buffering on ammonia excretion and Rhesus glycoprotein mRNA expression in rainbow trout. | 2008-10 |
|
| Ammonia inhibits the C-type natriuretic peptide-dependent cyclic GMP synthesis and calcium accumulation in a rat brain endothelial cell line. | 2008-05 |
|
| Role of angiotensin II in the enhancement of ammonia production and secretion by the proximal tubule in metabolic acidosis. | 2008-04 |
|
| Encephalopathy and cerebral edema in the setting of acute liver failure: pathogenesis and management. | 2008 |
|
| Non-convulsive status epilepticus secondary to valproic acid-induced hyperammonemic encephalopathy. | 2007-08 |
|
| cAMP mediates ammonia-induced programmed cell death in the microglial cell line BV-2. | 2007-04 |
|
| Expression of the ammonia transporter, rh C glycoprotein, in normal and neoplastic human kidney. | 2006-10 |
|
| [The most frequent allergens in allergic contact dermatitis]. | 2006-07-14 |
|
| Long-term correction of ammonia metabolism and prolonged survival in ornithine transcarbamylase-deficient mice following liver-directed treatment with adeno-associated viral vectors. | 2006-07 |
|
| Liver-specific loss of beta-catenin blocks glutamine synthesis pathway activity and cytochrome p450 expression in mice. | 2006-04 |
|
| Renal expression of the ammonia transporters, Rhbg and Rhcg, in response to chronic metabolic acidosis. | 2006-02 |
|
| Role of ammonia and nitric oxide in the decrease in plasma prolactin levels in prehepatic portal hypertensive male rats. | 2006 |
|
| Mechanisms of ammonia-induced astrocyte swelling. | 2005-12 |
|
| Anti-inflammatory effects of inhibiting the amine oxidase activity of semicarbazide-sensitive amine oxidase. | 2005-11 |
|
| Relationship between tumor necrosis factor-alpha and ammonia in patients with hepatic encephalopathy due to chronic liver failure. | 2005 |
|
| Functional identification of ion binding sites at the internal end of the pore in Shaker K+ channels. | 2003-05-15 |
|
| Inhibition of HIV-1 infection by zinc group metal compounds. | 1999-09 |
|
| Structure of cytochrome c nitrite reductase. | 1999-07-29 |
|
| Characterization of rabbit UDP-glucuronosyltransferase UGT1A7: tertiary amine glucuronidation is catalyzed by UGT1A7 and UGT1A4. | 1997-08-15 |
|
| Intracellular flux analysis applied to the effect of dissolved oxygen on hybridomas. | 1995-12 |
|
| Effects of valproate and citrulline on ammonium-induced encephalopathy. | 1994-01-01 |
|
| Cytoprotective effect of plasmin inhibitor on necrotizing agent-induced gastric lesions in rats. | 1989-05 |
|
| Venous, arterial, and arterialized-venous blood ammonia levels and their relationship to hepatic encephalopathy after propranolol. | 1988-03 |
|
| Possible mechanisms of anti-cholinergic drug-induced bradycardia. | 1988 |
|
| Pharmacological profiles of three new, potent and selective dopamine receptor agonists: N-0434, N-0437 and N-0734. | 1986-06-17 |
|
| Acute changes of blood ammonia may predict short-term adverse effects of valproic acid. | 1984-11 |
|
| The nitrogen-fixing complex of bacteria. | 1975-03-31 |
|
| A triphosphopyridine nucleotide-specific nitrite reductase from Escherichia coli. | 1961-12 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3743637
Intraperitoneal: 10 mM per 1 kg body weight
Oral: 40 mM per 1 kg body weight
Route of Administration:
Other
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:55:47 GMT 2025
by
admin
on
Mon Mar 31 17:55:47 GMT 2025
|
| Record UNII |
5138Q19F1X
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Related Record | Type |
|---|
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
LOINC |
25308-8
Created by
admin on Mon Mar 31 17:55:47 GMT 2025 , Edited by admin on Mon Mar 31 17:55:47 GMT 2025
|
||
|
LOINC |
53500-5
Created by
admin on Mon Mar 31 17:55:47 GMT 2025 , Edited by admin on Mon Mar 31 17:55:47 GMT 2025
|
||
|
LOINC |
22763-7
Created by
admin on Mon Mar 31 17:55:47 GMT 2025 , Edited by admin on Mon Mar 31 17:55:47 GMT 2025
|
||
|
EPA PESTICIDE CODE |
5302
Created by
admin on Mon Mar 31 17:55:47 GMT 2025 , Edited by admin on Mon Mar 31 17:55:47 GMT 2025
|
||
|
LOINC |
53081-6
Created by
admin on Mon Mar 31 17:55:47 GMT 2025 , Edited by admin on Mon Mar 31 17:55:47 GMT 2025
|
||
|
LOINC |
20682-1
Created by
admin on Mon Mar 31 17:55:47 GMT 2025 , Edited by admin on Mon Mar 31 17:55:47 GMT 2025
|
||
|
LOINC |
1841-6
Created by
admin on Mon Mar 31 17:55:47 GMT 2025 , Edited by admin on Mon Mar 31 17:55:47 GMT 2025
|
||
|
LOINC |
1840-8
Created by
admin on Mon Mar 31 17:55:47 GMT 2025 , Edited by admin on Mon Mar 31 17:55:47 GMT 2025
|
||
|
LOINC |
35254-2
Created by
admin on Mon Mar 31 17:55:47 GMT 2025 , Edited by admin on Mon Mar 31 17:55:47 GMT 2025
|
||
|
LOINC |
1842-4
Created by
admin on Mon Mar 31 17:55:47 GMT 2025 , Edited by admin on Mon Mar 31 17:55:47 GMT 2025
|
||
|
LOINC |
23656-2
Created by
admin on Mon Mar 31 17:55:47 GMT 2025 , Edited by admin on Mon Mar 31 17:55:47 GMT 2025
|
||
|
LOINC |
25850-9
Created by
admin on Mon Mar 31 17:55:47 GMT 2025 , Edited by admin on Mon Mar 31 17:55:47 GMT 2025
|
||
|
LOINC |
9309-6
Created by
admin on Mon Mar 31 17:55:47 GMT 2025 , Edited by admin on Mon Mar 31 17:55:47 GMT 2025
|
||
|
LOINC |
20683-9
Created by
admin on Mon Mar 31 17:55:47 GMT 2025 , Edited by admin on Mon Mar 31 17:55:47 GMT 2025
|
||
|
LOINC |
27039-7
Created by
admin on Mon Mar 31 17:55:47 GMT 2025 , Edited by admin on Mon Mar 31 17:55:47 GMT 2025
|
||
|
LOINC |
20684-7
Created by
admin on Mon Mar 31 17:55:47 GMT 2025 , Edited by admin on Mon Mar 31 17:55:47 GMT 2025
|
||
|
LOINC |
54349-6
Created by
admin on Mon Mar 31 17:55:47 GMT 2025 , Edited by admin on Mon Mar 31 17:55:47 GMT 2025
|
||
|
LOINC |
25851-7
Created by
admin on Mon Mar 31 17:55:47 GMT 2025 , Edited by admin on Mon Mar 31 17:55:47 GMT 2025
|
||
|
LOINC |
1839-0
Created by
admin on Mon Mar 31 17:55:47 GMT 2025 , Edited by admin on Mon Mar 31 17:55:47 GMT 2025
|
||
|
LOINC |
32664-5
Created by
admin on Mon Mar 31 17:55:47 GMT 2025 , Edited by admin on Mon Mar 31 17:55:47 GMT 2025
|
||
|
LOINC |
16363-4
Created by
admin on Mon Mar 31 17:55:47 GMT 2025 , Edited by admin on Mon Mar 31 17:55:47 GMT 2025
|
||
|
LOINC |
16362-6
Created by
admin on Mon Mar 31 17:55:47 GMT 2025 , Edited by admin on Mon Mar 31 17:55:47 GMT 2025
|
||
|
CFR |
21 CFR 862.1065
Created by
admin on Mon Mar 31 17:55:47 GMT 2025 , Edited by admin on Mon Mar 31 17:55:47 GMT 2025
|
||
|
LOINC |
15149-8
Created by
admin on Mon Mar 31 17:55:47 GMT 2025 , Edited by admin on Mon Mar 31 17:55:47 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
7664-41-7
Created by
admin on Mon Mar 31 17:55:47 GMT 2025 , Edited by admin on Mon Mar 31 17:55:47 GMT 2025
|
PRIMARY | |||
|
AMMONIA
Created by
admin on Mon Mar 31 17:55:47 GMT 2025 , Edited by admin on Mon Mar 31 17:55:47 GMT 2025
|
PRIMARY | |||
|
16134
Created by
admin on Mon Mar 31 17:55:47 GMT 2025 , Edited by admin on Mon Mar 31 17:55:47 GMT 2025
|
PRIMARY | |||
|
8007-57-6
Created by
admin on Mon Mar 31 17:55:47 GMT 2025 , Edited by admin on Mon Mar 31 17:55:47 GMT 2025
|
ALTERNATIVE | |||
|
4625
Created by
admin on Mon Mar 31 17:55:47 GMT 2025 , Edited by admin on Mon Mar 31 17:55:47 GMT 2025
|
PRIMARY | |||
|
C014333
Created by
admin on Mon Mar 31 17:55:47 GMT 2025 , Edited by admin on Mon Mar 31 17:55:47 GMT 2025
|
PRIMARY | |||
|
231-635-3
Created by
admin on Mon Mar 31 17:55:47 GMT 2025 , Edited by admin on Mon Mar 31 17:55:47 GMT 2025
|
PRIMARY | |||
|
100000077712
Created by
admin on Mon Mar 31 17:55:47 GMT 2025 , Edited by admin on Mon Mar 31 17:55:47 GMT 2025
|
PRIMARY | |||
|
1299884
Created by
admin on Mon Mar 31 17:55:47 GMT 2025 , Edited by admin on Mon Mar 31 17:55:47 GMT 2025
|
PRIMARY | |||
|
5138Q19F1X
Created by
admin on Mon Mar 31 17:55:47 GMT 2025 , Edited by admin on Mon Mar 31 17:55:47 GMT 2025
|
PRIMARY | |||
|
222
Created by
admin on Mon Mar 31 17:55:47 GMT 2025 , Edited by admin on Mon Mar 31 17:55:47 GMT 2025
|
PRIMARY | |||
|
m1758
Created by
admin on Mon Mar 31 17:55:47 GMT 2025 , Edited by admin on Mon Mar 31 17:55:47 GMT 2025
|
PRIMARY | Merck Index | ||
|
C45678
Created by
admin on Mon Mar 31 17:55:47 GMT 2025 , Edited by admin on Mon Mar 31 17:55:47 GMT 2025
|
CONCEPT | Industrial Aid | ||
|
C76698
Created by
admin on Mon Mar 31 17:55:47 GMT 2025 , Edited by admin on Mon Mar 31 17:55:47 GMT 2025
|
PRIMARY | |||
|
5138Q19F1X
Created by
admin on Mon Mar 31 17:55:47 GMT 2025 , Edited by admin on Mon Mar 31 17:55:47 GMT 2025
|
PRIMARY | |||
|
SUB12866MIG
Created by
admin on Mon Mar 31 17:55:47 GMT 2025 , Edited by admin on Mon Mar 31 17:55:47 GMT 2025
|
PRIMARY | |||
|
m1761
Created by
admin on Mon Mar 31 17:55:47 GMT 2025 , Edited by admin on Mon Mar 31 17:55:47 GMT 2025
|
PRIMARY | Merck Index | ||
|
D000641
Created by
admin on Mon Mar 31 17:55:47 GMT 2025 , Edited by admin on Mon Mar 31 17:55:47 GMT 2025
|
PRIMARY | |||
|
DTXSID0023872
Created by
admin on Mon Mar 31 17:55:47 GMT 2025 , Edited by admin on Mon Mar 31 17:55:47 GMT 2025
|
PRIMARY | |||
|
DB11118
Created by
admin on Mon Mar 31 17:55:47 GMT 2025 , Edited by admin on Mon Mar 31 17:55:47 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
LABELED -> NON-LABELED |
|
||
|
|
SUB_CONCEPT->SUBSTANCE |
|
||
|
|
SUB_CONCEPT->SUBSTANCE |
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
AMMONIA (ug/cigarette)
Canadian = 261.1 SD(90.3)
Imported = 1136.9 SD(613.8)
|
||
|
|
SUB_CONCEPT->SUBSTANCE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|